MetaBrain Biosystems is a deep-tech medical device company building a new class of closed-loop metabolic control systems for complex clinical care.

Our platform, MetaboCore™, continuously senses metabolic and physiological signals and delivers precision, nutrition-grade metabolic inputs under clinician supervision. Rather than treating disease endpoints, MetaBrain addresses the underlying metabolic instability that drives deterioration across:

• Oncology

• Cardiometabolic

• Neurodegenerative

• Obesity

• Other chronic inflammatory conditions

Designed for use in supervised clinical environments, the system integrates multi-modal sensing, programmable micro-infusion, and safety-critical control software enabling adaptive, real-time metabolic support without pharmacologic toxicity.

MetaBrain is a platform company, not a single-indication solution.

Our initial clinical focus is supportive oncology and metabolic stabilization, where preserving functional reserve and treatment tolerance can materially impact patient outcomes.

We are building the metabolic control layer of modern medicine clinically grounded, scalable, and designed for real-world adoption.